Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study
- Author
- GOODMAN, Shaun G1 ; COHEN, Marc2 ; FOX, Keith A. A7 ; LANGER, Anatoly8 ; BIGONZI, Frederique2 ; GURFINKEL, Enrique P3 ; RADLEY, David R2 ; LE IOUER, Veronique2 ; FROMELL, Gregg J3 ; DEMERS, Christine4 ; TURPIE, Alexander G. G5 ; CALIFF, Robert M6
[1] Canadian Heart Research Center, Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Canada
[2] Division of Cardiology, Allegheny University Hospitals, Hahnemann Division, Philadelphia, Pennsylvania, United States
[3] Rhone-Poulenc Rorer Corp., Antony, France
[4] Rhone-Poulenc Rorer Corp., Collegeville, Pennsylvania, United States
[5] Institute of Cardiology, Favaloro Foundation, Buenos Aires, Argentina
[6] Hopital St. Sacrement, Quebec, Canada
[7] McMaster University, Hamilton, Canada
[8] Duke University, Durham, North Carolina, United States - Conference title
- Myocardial Infarction Redefined. Conference
- Conference name
- Myocardial Infarction Redefined. Conference
- Source
Journal of the American College of Cardiology. 2000, Vol 36, Num 3, pp 693-698 ; ref : 17 ref
- CODEN
- JACCDI
- ISSN
- 0735-1097
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Elsevier Science, New York, NY
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Angor instable Chimiothérapie Efficacité traitement Enoxaparine sodique Etude comparative Glycosaminoglycane Homme Héparine Infarctus Myocarde Récidive Traitement Anticoagulant Appareil circulatoire pathologie Cardiopathie coronaire Héparine bas poids moléculaire Myocarde pathologie
- Keyword (en)
- Variant angina Chemotherapy Treatment efficiency Enoxaparin sodium Comparative study Glycosaminoglycan Human Heparin Infarct Myocardium Relapse Treatment Anticoagulant Cardiovascular disease Coronary heart disease Low molecular weight heparin Myocardial disease
- Keyword (es)
- Angina inestable Quimioterapia Eficacia tratamiento Enoxaparina sódica Estudio comparativo Glicosaminoglicano Hombre Heparina Infarto Miocardio Recaida Tratamiento Anticoagulante Aparato circulatorio patología Cardiopatía coronaria Heparina bajo peso molecular Miocardio patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02G Blood. Blood coagulation. Reticuloendothelial system
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1500022
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S0735-1097(00)00808-1 
https://dx.doi.org/10.1016/S0735-1097(00)00808-1
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(00)00808-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"693\";s:8:\"\u0000*\u0000epage\";s:3:\"698\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GOODMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Shaun G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"COHEN, Marc\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:15:\"LANGER, Anatoly\";i:3;s:19:\"BIGONZI, Frederique\";i:4;s:20:\"GURFINKEL, Enrique P\";i:5;s:15:\"RADLEY, David R\";i:6;s:19:\"LE IOUER, Veronique\";i:7;s:16:\"FROMELL, Gregg J\";i:8;s:17:\"DEMERS, Christine\";i:9;s:22:\"TURPIE, Alexander G. G\";i:10;s:16:\"CALIFF, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:43:\"Myocardial Infarction Redefined. Conference\";s:8:\"\u0000*\u0000title\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(00)00808-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"693\";s:8:\"\u0000*\u0000epage\";s:3:\"698\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GOODMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Shaun G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"COHEN, Marc\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:15:\"LANGER, Anatoly\";i:3;s:19:\"BIGONZI, Frederique\";i:4;s:20:\"GURFINKEL, Enrique P\";i:5;s:15:\"RADLEY, David R\";i:6;s:19:\"LE IOUER, Veronique\";i:7;s:16:\"FROMELL, Gregg J\";i:8;s:17:\"DEMERS, Christine\";i:9;s:22:\"TURPIE, Alexander G. G\";i:10;s:16:\"CALIFF, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:43:\"Myocardial Infarction Redefined. Conference\";s:8:\"\u0000*\u0000title\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(00)00808-1\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(00)00808-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"693\";s:8:\"\u0000*\u0000epage\";s:3:\"698\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GOODMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Shaun G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"COHEN, Marc\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:15:\"LANGER, Anatoly\";i:3;s:19:\"BIGONZI, Frederique\";i:4;s:20:\"GURFINKEL, Enrique P\";i:5;s:15:\"RADLEY, David R\";i:6;s:19:\"LE IOUER, Veronique\";i:7;s:16:\"FROMELL, Gregg J\";i:8;s:17:\"DEMERS, Christine\";i:9;s:22:\"TURPIE, Alexander G. G\";i:10;s:16:\"CALIFF, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:43:\"Myocardial Infarction Redefined. Conference\";s:8:\"\u0000*\u0000title\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(00)00808-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"693\";s:8:\"\u0000*\u0000epage\";s:3:\"698\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GOODMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Shaun G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"COHEN, Marc\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:15:\"LANGER, Anatoly\";i:3;s:19:\"BIGONZI, Frederique\";i:4;s:20:\"GURFINKEL, Enrique P\";i:5;s:15:\"RADLEY, David R\";i:6;s:19:\"LE IOUER, Veronique\";i:7;s:16:\"FROMELL, Gregg J\";i:8;s:17:\"DEMERS, Christine\";i:9;s:22:\"TURPIE, Alexander G. G\";i:10;s:16:\"CALIFF, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:43:\"Myocardial Infarction Redefined. Conference\";s:8:\"\u0000*\u0000title\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(00)00808-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"693\";s:8:\"\u0000*\u0000epage\";s:3:\"698\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GOODMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Shaun G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"COHEN, Marc\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:15:\"LANGER, Anatoly\";i:3;s:19:\"BIGONZI, Frederique\";i:4;s:20:\"GURFINKEL, Enrique P\";i:5;s:15:\"RADLEY, David R\";i:6;s:19:\"LE IOUER, Veronique\";i:7;s:16:\"FROMELL, Gregg J\";i:8;s:17:\"DEMERS, Christine\";i:9;s:22:\"TURPIE, Alexander G. G\";i:10;s:16:\"CALIFF, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:43:\"Myocardial Infarction Redefined. Conference\";s:8:\"\u0000*\u0000title\";s:168:\"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
